Surgery Websites
Transplant Surgery »  Meet the Team »  Endocrinology »  Umesh Masharani, M.B., M.D.
Umesh Masharani, M.B., M.D.

Umesh Masharani, M.B., M.D.

Clinical Professor of Medicine
Division of Endocrinology
Department of Medicine

Contact Information

Endocrinology/Metabolism
400 Parnassus Ave.
ACC 585, Box 1222
San Francisco, CA 94143
umeshm@medicine.ucsf.edu

All Clinic Information

Open Popup
  • Middlesex Medical School, London 1982
  • Birmingham Teaching Hospital, United Kingdom, Internal Medicine 1985
  • UCSF Medical Center, Endocrinology/Metabolism 1993
  • American Board of Internal Medicine - Primary Certificate
  • American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism - Subspecialty
  • Diabetes Center
  • UCSF Kidney Transplant Program
  • Adrenal Insufficiency
  • Cushings Disease
  • Pheochromocytoma
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Hypoglycemic Agents
  • Polymorphism, Genetic
  • Polymorphism, Restriction Fragment Length

Dr. Masharani is a Clinical Professor of Endocrinology and Metabolism in the Department of Medicine, UCSF. He has an active clinical practice treating patients with diabetes and other endocrine disorders. . As a member of the UCSF Islet Transplant Group, Dr Masharani assists in managing diabetes of patients admitted to UCSF for islet transplantation evaluation.

Dr. Masharani is Co-Chair of the University of California, San Francisco Diabetes Teaching Center Annual Patient Symposium. Dr. Masharani is the author of Diabetes Demystified, a complete guide to understanding and managing diabetes.

Dr. Masharani is a Co-Investigator on a number of NIH funded diabetes studies at UCSF. His research includes studies evaluating the effect of chromium and alpha lipoic acid on insulin resistance, and anti-CD3 antibodies on new onset type 1 diabetes and multi-ethnic studies addressing the interactive relationships among disease management, glucose control and depression in patients with type 2 diabetes.

MOST RECENT PUBLICATIONS FROM A TOTAL OF 63
Publications provided by UCSF Profiles, powered by CTSI.
  1. Shumway M, Fisher L, Hessler D, Bowyer V, Polonsky WH, Masharani U. Economic costs of implementing group interventions to reduce diabetes distress in adults with type 1 diabetes mellitus in the T1-REDEEM trial. J Diabetes Complications. 2019 Nov; 33(11):107416. View in PubMed
  2. Hessler D, Fisher L, Polonsky W, Strycker L, Parra J, Bowyer V, Dedhia M, Masharani U. There is value in treating elevated levels of diabetes distress: the clinical impact of targeted interventions in adults with Type 1 diabetes. Diabet Med. 2020 01; 37(1):71-74. View in PubMed
  3. Fisher L, Hessler D, Polonsky W, Strycker L, Bowyer V, Masharani U. Toward effective interventions to reduce diabetes distress among adults with type 1 diabetes: Enhancing?Emotion regulation and cognitive skills. Patient Educ Couns. 2019 08; 102(8):1499-1505. View in PubMed
  4. Kim S, Dillon WP, Hope TA, El-Sayed IH, van Zante A, Wu K, Masharani U. Ectopic Thyroid-Stimulating Hormone-Secreting Pituitary Adenoma of the Nasopharynx Diagnosed by Gallium 68 DOTATATE Positron Emission Tomography/Computed Tomography. World Neurosurg. 2019 05; 125:400-404. View in PubMed
  5. Wentworth KL, Masharani U, Hsiao EC. Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva. Br J Clin Pharmacol. 2019 06; 85(6):1180-1187. View in PubMed
  6. View All Publications

 

Site Directory
    X